The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates

Active, not recruitingOBSERVATIONAL
Enrollment

208

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

April 19, 2024

Study Completion Date

April 19, 2024

Conditions
FrailtySarcopeniaCOVID-19
Interventions
BEHAVIORAL

COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC

This is a single-center, retrospective study that uses de-identified, anonymized patient data. Data from 369 liver transplant candidates who underwent pre-transplant frailty assessments at the Liver Institute at Methodist Dallas from April 1, 2018 to February 28, 2022. The study data will be divided into cohorts: pre-COVID and COVID. Specifically, the pre-COVID period will consist of the dates between April 1st, 2018 and March 12, 2020, while the COVID period will consist of the dates between March 13, 2020 and February 28th, 2022.

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER